Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Protective Effect of Tunisian Flaxseed Oil against Bleomycin-Induced Pulmonary Fibrosis in Rats.

Abidi A, Kourda N, Feki M, Ben Khamsa S.

Nutr Cancer. 2019 Jun 1:1-13. doi: 10.1080/01635581.2019.1622741. [Epub ahead of print]

PMID:
31155950
2.

Hypericum Humifusum Leaves Attenuates Hepatic Ischemia-Reperfusion Injury in a Rat Model.

Ferchichi H, Salouage I, Bacha S, Kourda N, Jebabli N, Gaies E, Klouz A, Trabelsi S.

Ann Hepatol. 2018 January-February;17(1):144-152. doi: 10.5604/01.3001.0010.7546.

3.

Nigella sativa, a traditional Tunisian herbal medicine, attenuates bleomycin-induced pulmonary fibrosis in a rat model.

Abidi A, Robbe A, Kourda N, Ben Khamsa S, Legrand A.

Biomed Pharmacother. 2017 Jun;90:626-637. doi: 10.1016/j.biopha.2017.04.009. Epub 2017 Apr 14.

PMID:
28412654
4.

Protective Effect of Pistacia lentiscus Oil Against Bleomycin-Induced Lung Fibrosis and Oxidative Stress in Rat.

Abidi A, Aissani N, Sebai H, Serairi R, Kourda N, Ben Khamsa S.

Nutr Cancer. 2017 Apr;69(3):490-497. doi: 10.1080/01635581.2017.1283423. Epub 2017 Feb 17.

PMID:
28287322
5.

Effect of Pistacia lentiscus oil on experimental pulmonary fibrosis.

Abidi A, Serairi Beji R, Kourda N, Ennigrou S, Ksouri R, Jameleddine S.

Tunis Med. 2016 Jul;94(7):401-406.

6.

Protective effect of Ulva lactuca extract during hepatic cold preservation in rats.

Ferchichi H, Bacha S, Kourda N, Melaouhia S, Gaies E, Lakhal M, Klouz A, Trabelsi S, Salouage I.

Tunis Med. 2016 Apr;94(4):276-283.

7.

Animal model of liver ischemia reperfusion: biochemical and histological evaluation.

Ferchichi H, Bacha S, Kourda N, Gaies E, Melaouhia S, Lakhal M, Klouz A, Trabelsi S, Salouage I.

Tunis Med. 2016 Mar;94(3):235-43.

8.

Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer Therapy.

Omrane I, Medimegh I, Baroudi O, Ayari H, Bedhiafi W, Stambouli N, Ferchichi M, Kourda N, Bignon YJ, Uhrhammer N, Mezlini A, Bougatef K, Benammar-Elgaaied A.

PLoS One. 2015 Jun 17;10(6):e0128911. doi: 10.1371/journal.pone.0128911. eCollection 2015.

9.

[Immunohistochemical analysis of mismatch repair proteins in colorectal adenomas].

Rammeh S, Sabbegh Znaidi N, Arfaoui A, Ayouni K, Blel A, Farah F, Zidi Y, Najjar T, Kourda N, Said Y, Zermani R.

Tunis Med. 2014 Oct;92(10):622-5. French.

10.

[Odontogenic tumor with Liesegang rings].

Attafi S, Blel A, Aloui R, Fareh F, Zermani R, Kourda N.

Ann Pathol. 2015 Apr;35(2):194-6. doi: 10.1016/j.annpat.2015.01.014. Epub 2015 Mar 21. French. No abstract available.

PMID:
25801994
11.

Means of evaluation and protection from doxorubicin-induced cardiotoxicity and hepatotoxicity in rats.

Salouege I, Ben Ali R, Ben Saïd D, Elkadri N, Kourda N, Lakhal M, Klouz A.

J Cancer Res Ther. 2014 Apr-Jun;10(2):274-8. doi: 10.4103/0973-1482.136557.

12.

[Prostate cancer with bilateral testicular metastasis].

Kerkeni W, Bouzouita A, Selmi MS, Kourda N, Cherif M, Derouich A, Zermani R, Ben Slama MR, Chebil M.

Tunis Med. 2014 Feb;92(2):169-70. French. No abstract available.

13.

Obesity and renal cancer: Role of adipokines in the tumor-immune system conflict.

Gati A, Kouidhi S, Marrakchi R, El Gaaied A, Kourda N, Derouiche A, Chebil M, Caignard A, Perier A.

Oncoimmunology. 2014 Jan 1;3(1):e27810. Epub 2014 Jan 16. Review.

14.

MicroRNAs 146a and 147b biomarkers for colorectal tumor's localization.

Omrane I, Kourda N, Stambouli N, Privat M, Medimegh I, Arfaoui A, Uhrhammer N, Bougatef K, Baroudi O, Bouzaienne H, Marrakchi R, Bignon YJ, Benammar-Elgaaied A.

Biomed Res Int. 2014;2014:584852. doi: 10.1155/2014/584852. Epub 2014 Mar 30.

15.

[A recently described entity of digestive tract].

Ben Salem A, Znaidi-Sabbegh N, Rammeh S, Zidi Y, Fereh F, Kourda N, Zermani R.

Ann Pathol. 2014 Apr;34(2):112-4. doi: 10.1016/j.annpat.2014.02.016. Epub 2014 Mar 18. French. No abstract available.

PMID:
24703019
16.

Significant association between interleukin-17A polymorphism and colorectal cancer.

Omrane I, Marrakchi R, Baroudi O, Mezlini A, Ayari H, Medimegh I, Stambouli N, Kourda N, Bouzaienne H, Uhrhammer N, Bougatef K, Bignon YJ, Benammar-Elgaaied A.

Tumour Biol. 2014 Jul;35(7):6627-32. doi: 10.1007/s13277-014-1890-4. Epub 2014 Apr 4.

PMID:
24699997
17.

TP53 mutations in colorectal cancer from Tunisia: relationships with site of tumor origin, microsatellite instability and KRAS mutations.

Aissi S, Buisine MP, Zerimech F, Kourda N, Moussa A, Manai M, Porchet N.

Mol Biol Rep. 2014 Mar;41(3):1807-13. doi: 10.1007/s11033-014-3030-z. Epub 2014 Jan 18.

PMID:
24443225
18.

Significant association between IL23R and IL17F polymorphisms and clinical features of colorectal cancer.

Omrane I, Baroudi O, Bougatef K, Mezlini A, Abidi A, Medimegh I, Stambouli N, Ayari H, Kourda N, Uhrhammer N, Bignon YJ, Benammar Elgaaied A, Marrakchi R.

Immunol Lett. 2014 Mar-Apr;158(1-2):189-94. doi: 10.1016/j.imlet.2014.01.002. Epub 2014 Jan 14.

PMID:
24440568
19.

KRAS mutations in colorectal cancer from Tunisia: relationships with clinicopathologic variables and data on TP53 mutations and microsatellite instability.

Aissi S, Buisine MP, Zerimech F, Kourda N, Moussa A, Manai M, Porchet N.

Mol Biol Rep. 2013 Nov;40(11):6107-12.

PMID:
24078161
20.

Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia.

Aissi S, Buisine MP, Zerimech F, Kourda N, Moussa A, Manai M, Porchet N.

World J Gastroenterol. 2013 Aug 28;19(32):5286-94. doi: 10.3748/wjg.v19.i32.5286.

21.

Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.

Omrane I, Baroudi O, Kourda N, Bignon YJ, Uhrhammer N, Desrichard A, Medimegh I, Ayari H, Stambouli N, Mezlini A, Bouzayenne H, Marrakchi R, Benammar-Elgaaid A, Bougatef K.

Tumour Biol. 2014 Jan;35(1):545-51. doi: 10.1007/s13277-013-1075-6. Epub 2013 Aug 16.

PMID:
23949880
22.

Renal epithelioid angiomyolipoma.

Cherif M, Ktari K, Kerkeni W, Bouzouita A, Kourda N, Rajhi H, Ben Slama R, Chebil M.

Tunis Med. 2013 May;91(5):358-9. No abstract available.

23.

Impact of smoking intensity on outcomes of patients with non muscle invasive bladder cancer treated by BCG immunotherapy.

Ajili F, Kourda N, Karay S, Darouiche A, Chebil M, Boubaker S.

Ultrastruct Pathol. 2013 Aug;37(4):273-7. doi: 10.3109/01913123.2013.770111. Epub 2013 May 1.

PMID:
23634794
24.

Prognostic value of Pheochromocytoma of the Adrenal Gland Scaled Score (Pass score) tests to separate benign from malignant neoplasms.

Mlika M, Kourda N, Zorgati MM, Bahri S, Ben Ammar S, Zermani R.

Tunis Med. 2013 Mar;91(3):209-15.

25.

Glandular odontogenic cyst.

Landoulsi A, Marrakchi J, Kourda N, Helali M, Znaidi N, Zitouni K, Zairi I, Ben Jilani S, Adouani A.

Tunis Med. 2013 Feb;91(2):165-7. No abstract available.

26.

Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy.

Ajili F, Kourda N, Darouiche A, Chebil M, Boubaker S.

Ultrastruct Pathol. 2013 Feb;37(1):56-61. doi: 10.3109/01913123.2012.728688.

PMID:
23383616
27.

[Ileocolic intussusception from metastatic renal cell carcinoma].

Kerkeni W, Bouzouita A, Jarraya H, Selmi MS, Cherif M, Derouich A, Kourda N, Dziri C, Zermani R, Ben Slama MR, Chebil M.

Prog Urol. 2013 Jan;23(1):73-5. doi: 10.1016/j.purol.2012.08.273. Epub 2012 Sep 15. French.

PMID:
23287487
28.

A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.

Neuzillet Y, Paoletti X, Ouerhani S, Mongiat-Artus P, Soliman H, de The H, Sibony M, Denoux Y, Molinie V, Herault A, Lepage ML, Maille P, Renou A, Vordos D, Abbou CC, Bakkar A, Asselain B, Kourda N, El Gaaied A, Leroy K, Laplanche A, Benhamou S, Lebret T, Allory Y, Radvanyi F.

PLoS One. 2012;7(12):e48993. doi: 10.1371/journal.pone.0048993. Epub 2012 Dec 13.

29.

Aurora A overexpression and pVHL reduced expression are correlated with a bad kidney cancer prognosis.

Ferchichi I, Kourda N, Sassi S, Romdhane KB, Balatgi S, Cremet JY, Prigent C, Elgaaied AB.

Dis Markers. 2012;33(6):333-40. doi: 10.3233/DMA-2012-00942.

30.

[Is there a link between the occurrence of Kidney cancer and hypertension in Tunisian population?].

Ferchichi I, Kourda N, Derouiche A, Baltagi S, Chebil M, Benammar-Elgaaied A.

Tunis Med. 2012 May;90(5):397-400. French.

31.

[Primary mediastinal melanoma].

Ourari-Dhahri B, Farah S, Aouina H, Ben Amar J, Azzabi S, Baccar Mouhamed A, Kourda N, El Gharbi L, Bouacha H.

Tunis Med. 2012 Apr;90(4):339-40. French. No abstract available.

32.

Salivary duct carcinoma of the parotid gland.

Mlika M, Kourda N, Zidi Y, Aloui R, Zneidi N, Rammeh S, Zermani R, Jilani SB.

J Oral Maxillofac Pathol. 2012 Jan;16(1):134-6. doi: 10.4103/0973-029X.92992.

33.

[Retiform Sertoli-Leydig tumor with heterologous mucinous differentiation].

Adouni O, Kourda N, Aloui R, Zermani R, Abdellatif C, Ben Jilani S.

Tunis Med. 2012 Feb;90(2):187-9. French. No abstract available.

34.

Prognostic value of Bcl-2 and Bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus Calmette-Guerin immunotherapy.

Ajili F, Kaabi B, Darouiche A, Tounsi H, Kourda N, Chebil M, Manai M, Boubaker S.

Ultrastruct Pathol. 2012 Feb;36(1):31-9. doi: 10.3109/01913123.2011.620221.

PMID:
22292735
35.

[Primitive small cell carcinoma of the urinary bladder].

Adouni Naili O, Farah-Klibi F, Kourda N, Zidi-Mouaffak Y, Zermani R, Chebil M, Ben Jilani S.

Tunis Med. 2011 Dec;89(12):943-4. French. No abstract available.

36.

Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?

Hmida NB, Ben Ahmed M, Moussa A, Rejeb MB, Said Y, Kourda N, Meresse B, Abdeladhim M, Louzir H, Cerf-Bensussan N.

Am J Gastroenterol. 2012 Apr;107(4):604-11. doi: 10.1038/ajg.2011.397. Epub 2011 Nov 22.

37.

Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo.

Ben Ahmed M, Zaraa I, Rekik R, Elbeldi-Ferchiou A, Kourda N, Belhadj Hmida N, Abdeladhim M, Karoui O, Ben Osman A, Mokni M, Louzir H.

Pigment Cell Melanoma Res. 2012 Jan;25(1):99-109. doi: 10.1111/j.1755-148X.2011.00920.x. Epub 2011 Oct 25.

PMID:
21985183
38.

Giant trichoblastoma of the scalp.

Landolsi A, Khaled A, Bougacha L, Helali H, Kourda N, Fazaa B, Zermani R, Kamoun MR, Adouani A.

Tunis Med. 2011 Jun;89(6):569-72.

39.

[Cecal perforation in a kidney transplant patient: disseminated histoplasmosis].

Kourda N, Mlika M, Zidi YS, Zermani R, Ben Jilani S.

Med Trop (Mars). 2010 Dec;70(5-6):533-6. French.

PMID:
21520661
40.

[Pediatric mandibular ameloblastic fibro-odontoma].

Zehani A, Kourda N, Landolsi A, Adouani A, Zermani R, Ben Jilani S.

Rev Stomatol Chir Maxillofac. 2011 Jun;112(3):187-9. doi: 10.1016/j.stomax.2011.03.001. Epub 2011 Apr 13. French.

PMID:
21492889
41.

Lidocaïne test for easier and less time consuming assessment of liver function in several hepatic injury models.

Ben Said D, Ben Ali R, Ferchichi H, Salouage I, Ouanes L, Gaïes E, Trabelsi S, Kooli E, Kourda N, Abdelmoula J, Lakhal M, Klouz A.

Hepatol Int. 2011 Dec;5(4):941-8. doi: 10.1007/s12072-011-9270-2. Epub 2011 Mar 23.

PMID:
21484114
42.

Rectal leiomyosarcoma: report on two cases and a practical approach to differential diagnosis.

Kourda N, Kourda J, Aouam J, Zaouche A, Ben Jilani SB, Zermani R.

Pathologica. 2010 Oct;102(5):417-9.

PMID:
21361124
43.

Lynch syndrome in Tunisia: first description of clinical features and germline mutations.

Moussa SA, Moussa A, Kourda N, Mezlini A, Abdelli N, Zerimech F, Najjar T, Jilani SB, Porchet N, Ayed FB, Manai M, Buisine MP.

Int J Colorectal Dis. 2011 Apr;26(4):455-67. doi: 10.1007/s00384-010-1129-9. Epub 2011 Feb 11.

PMID:
21311894
44.

Report of two cases of primary amelanotic and melanotic anorectal malignant melanoma.

El Amine El Hadj O, Kourda N, Zermani R, Bedoui R, Dziri C, Jilani SB.

Tunis Med. 2011 Feb;89(2):218-9. No abstract available.

45.

[The myofibroblastic inflammatory tumours: A fortuitous association or an unknown postpartum complication].

Chelbi E, Chadli-Debbiche A, Ferchiou M, Ajmi C, Kourda N, Labbène N, Khayat O, Zermani R, Cherif R, Ben Ayed M.

Gynecol Obstet Fertil. 2011 Jan;39(1):e27-30. doi: 10.1016/j.gyobfe.2010.08.020. Epub 2010 Dec 22. French.

PMID:
21183382
46.

Hepatocellular carcinoma with sarcomatous change.

Said Y, Trabelsi S, Kourda N, Debbeche R, Bouzaidi S, Salem M, Najjar T.

Tunis Med. 2010 Dec;88(12):957-60.

47.

[An exceptional hepatic tumor].

Mlika M, Zidi-Moaffak Y, Farah F, Kourda N, Cherif E, Baltagi-Ben Jilani S, Zermani R.

Tunis Med. 2010 Dec;88(12):954-6. French.

48.

[Primary diffuse large B cell lymphoma of the duodenal bulb].

Said Y, Abbès L, Trabelsi S, Kourda N, Debbeche R, Bouzaidi S, Najjar T.

Tunis Med. 2010 Nov;88(11):861-2. French. No abstract available.

49.

The utility of alpha-methyl CoA racemase (P504S) expression as a marker of renal cell carcinomas.

Kourda N, Mlika M, Derouiche A, Zidi-Moaffak Y, Chebil M, Zermani R, Jilani SB.

Tunis Med. 2010 Sep;88(9):651-4.

50.

Primary orbital hemangiopericytoma: an unusual cause of unilateral proptosis.

Limaiem R, Limaiem F, Kourda N, Zairi I, Chaabouni A, El Matri L.

Can J Neurol Sci. 2010 Mar;37(2):279-82. No abstract available.

PMID:
20437945

Supplemental Content

Loading ...
Support Center